IDO1 and COVID-19: Activation of cytokines stimulates IDO enzymatic activity to perform tryptophan catabolism which controls the propagation of pulmonary hyperinflammation, hypertension, and pneumonia among COVID-19 patients with its immunoregulatory and antimicrobial activities [34,66,67].